Jane Street’s Harvard Bioscience HBIO Stock Holding History

Jane Street's HBIO Position: Q2 2026 in Review

Jane Street reduced its Harvard Bioscience (HBIO) stake by 41% in Q2 2026, selling an estimated $59K and leaving 13,982 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #10677.

Jane Street first reported a position in HBIO in Q2 2016 and has held it in 15 quarters since. The position peaked at $357K in Q2 2019. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

• Jane Street held 13,982 shares of Harvard Bioscience worth $86K as of Q2 2026.
• Jane Street sold 9,848 Harvard Bioscience shares in Q2 2026, an estimated $59K.
• Harvard Bioscience made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10677 holding.
• Jane Street first reported a position in Harvard Bioscience in Q2 2016 and has held it in 15 quarters since.
• Jane Street's Harvard Bioscience position peaked at $357K in Q2 2019.
• 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.